CIPLA HYDROCORTISONE (as sodium succinate) 100 mg powder for injection vial — recall
Health products · Australia · 2026-11-16
CIPLA HYDROCORTISONE 100 mg powder for injection vial, glass particle risk
| Country | Australia |
|---|---|
| Category | Health products |
| Published | 2026-11-16 |
| Brand | CIPLA |
| Company | Cipla Australia Pty Ltd |
| Batch / expiry | Batch Number: HY0102501A; Expiry Date: 03/2027 |
| Product type | Medicine |
| Registration no. (ARTG) | 373394 |
| Recall level | Retail |
| Hazard class | Class II |
| Reason | The presence of a glass particle was reported in a vial of Hydrocortisone (as sodium succinate) 100 mg powder for injection vial. The contaminant was identified as a single glass fragment measuring approximately 8.88 × 6.13 × 1.04 mm length x width x height. The observed glass particle will not pass through the standard injection needle. Although the particle is relatively large and likely to be detected during preparation, the possibility of fragmentation into smaller particles cannot be excluded. Given the intravenous route of administration, if smaller fragments were inadvertently admini… |
| Recall type | Recall |
| Remedy | All customers are to: - Isolate and quarantine Batch HY0102501A with Expiry date: 03/2027 immediately and remove from further sale and distribution. Wholesalers are to: - Contact hospitals and/or health institutions where the affected batch was sold. Hospitals and Pharmacies are to: - Contact their wholesaler, who will provide further instructions on how to return or destroy the product and options to claim credit or resupply of product to replace affected stock. |
| Affected area | Australia |
| Recall number | RC-2026-RN-00935-1 |
| Official notice | View source ↗ |
Get alerted when Cipla has another recall
Free: we'll email you when Cipla appears in a new official recall across 11 markets, including the US, EU and Japan.
Watch Cipla recalls — free →What this means for sellers
| Likely platform / channel actions | Retailers/importers typically pull and return stock; similar products may face tighter border checks. |
|---|---|
| Self-check for comparable products | Environmental/batch micro testing; cold-chain records. |
| Rules & standards likely involved | the destination market's product-safety rules and mandatory standards |
🚨 Delisted or named by a regulator? Leave your details and situation — we'll assess and get back to you. Contact us →
General guidance only — not compliance or legal advice; the official notice and applicable law prevail.
Stay ahead of recalls like this
Get overseas recalls that matter to you (China-origin highlighted) + top hazards — one email a week. Free, unsubscribe anytime.
By subscribing you agree to our Privacy Policy & Terms (incl. cross-border data processing).
Related health products recalls
- Caruso’s Immune Aid 60 film coated tabletsAustralia · 2026-11-16
- Deep Heat Extra Strength 100g CreamAustralia · 2026-09-03
- My Immune Cold + FluAustralia · 2026-11-18
- Xiao Yan Li Dan Tablet, High Strength Chuan Xin Lian Antiphlogistic Tablet and Lian Zhi X…Australia · 2026-11-18